Metabolites derived from gut microbiota mitigate chemoresistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the third-leading cause of tumor-related deaths. The gut microbiota has gained attention in cancer treatment, due to its influence on the immune system and drug activity.